Doose Syndrome, also known as myoclonic-astatic epilepsy, is a form of epilepsy in which the genetic etiology has been somewhat elusive. A recent study by Carvill et al (Am J Hum Genet 2015 May 7;96(5):808-15. doi: 10.1016/j.ajhg.2015.02.016) reports that pathogenic variants in GAT-1, encoded by SLC6A1, can be responsible for up to 4% of cases of myoclonic-astatic epilepsy. Carvill et al. focused on this gene in particular for targeted studies due to reports of individuals with myoclonic-astatic epilepsy and chromosome deletions in the region covering this gene, as well as functional information about GAT-1. Two truncations and four missense alterations in SLC6A1 were uncovered by targeted sequencing individuals with myoclonic-atonic seizures (MAE). Hilary Vernon, MD PhD
Leave a Reply
You must be logged in to post a comment.
The OMMBID Blog

For the comprehensive coverage of the topics mentioned here, visit the continually updated online version of the textbook that continues to define medical genetics:
Scriver's www.ommbid.com.
Related Posts
- Mutation in DMD as a cause of non-specific X-linked intellectual disability without overt muscular dystrophy
- Mutations in CoA Synthase as a cause of NBIA
- Do all nerve cells of an individual have the same genome?
- GFAP mutations, age at onset and clinical subtypes in Alexander disease
- Lafora disease and mTOR
Follow Us
Topics
- Archive
- Books
- Courses
- Exome sequencing
- Genetics in Canada
- Historical perspectives
- In the news
- Meetings
- New IEM
- Newborn screening
- OMMBID Updates
- Part 02: PERSPECTIVES
- Part 03: GENERAL THEMES
- Part 04: CANCER
- Part 05: CHROMOSOMES
- Part 06: DIAGNOSTIC APPROACHES
- Part 07: CARBOHYDRATES
- Part 08: AMINO ACIDS
- Part 09: ORGANIC ACIDS
- Part 10: DISORDERS OF MITOCHONDRIAL FUNCTION
- Part 11: PURINES AND PYRIMIDINES
- Part 12: LIPIDS
- Part 13: PORPHYRINS
- Part 14: METALS
- Part 15: PEROXISOMES
- Part 16: LYSOSOMAL DISORDERS
- Part 17: VITAMINS
- Part 18: HORMONES
- Part 19: BLOOD
- Part 20: IMMUNE AND DEFENSE SYSTEMS
- Part 21: MEMBRANE TRANSPORT DISORDERS
- Part 22: CONNECTIVE TISSUE
- Part 23: CARDIOVASCULAR SYSTEM
- Part 24: KIDNEY
- Part 25: MUSCLE
- Part 27: SKIN
- Part 28: NEUROGENETICS
- Part 29: EYE
- Part 30: MULTISYSTEM INBORN ERRORS OF DEVELOPMENT
- Tools
- Treatment
- Websites
- _